Northern Kentucky’s St. Elizabeth Hospital the First Site to Dose COVID-19 Patients with PUL-042

Northern Kentucky’s St. Elizabeth Hospital the First Site to Dose COVID-19 Patients with PUL-042

St. Elizabeth Hospital in Edgewood, Kentucky, was selected as the first clinical investigational site for a Phase II clinical trial studying a new drug to treat COVID-19 called PUL-042, an inhalation solution under investigation to help COVID-19 from progressing in...

Pin It on Pinterest